Tpg Financial Advisors, LLC Edwards Lifesciences Corp Transaction History

Tpg Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	BUY	$86.5 - $128.27 $6,747 - $10,005	78 Added 1.9%	4,187 $398,000
Q1 2022 Apr 14, 2022	BUY	$101.96 - $128.34 $11,725 - $14,759	115 Added 2.88%	4,109 $484,000
Q4 2021 Jan 14, 2022	BUY	$106.37 - $130.68 $54,035 - $66,385	508 Added 14.57%	3,994 $517,000
Q3 2021 Oct 08, 2021	BUY	$102.91 - $122.75 $53,924 - $64,321	524 Added 17.69%	3,486 $395,000
Q2 2021 Jul 13, 2021	BUY	$83.84 - $104.76 $19,534 - $24,409	233 Added 8.54%	2,962 $307,000
Q1 2021 Apr 16, 2021	BUY	$78.68 - $90.67 $214,717 - $247,438	2,729 New	2,729 $228,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Tpg Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tpg Financial Advisors, LLC with notifications on news.